Hint mode is switched on Switch off

NewAmsterdam Pharma, ordinary share
NAMS, NL00150012L7

Add a stock to WL
Choose all Reset all
NewAmsterdam Pharma, сountry — Netherlands
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
NewAmsterdam Pharma operates as a pharmaceutical company. The Company focuses on the research and development of transformative therapies for cardio-metabolic diseases. NewAmsterdam Pharma serves customers in the Netherlands.
  • Issuer
  • Full borrower / issuer name
    NewAmsterdam Pharma Co NV
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    NAMS
  • Placement
    13.12.2024
  • Lock up period
    180
  • Number of papers
    12,117,347
  • Volume of raised funds
    296.88 mln USD
  • Placement share
    11.62%
  • Final placement price
    24.5 USD
  • Price change since placement date
    25.35%
  • By capitalization
    2,554.93 mln USD

IFRS/US GAAP reports

2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
IV q eng
2022
IV q eng
Show all Hide

Related Stock indices

Indicators

News

02/06/2026 NewAmsterdam Pharma: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
20/04/2026 NewAmsterdam Pharma: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
05/11/2025 NewAmsterdam Pharma: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
12/08/2025 NewAmsterdam Pharma: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
11/07/2025 NewAmsterdam Pharma: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.